Intravenous Lidocaine and Mexiletine in the Management of Trigeminal Autonomic Cephalalgias
- 514 Downloads
Lidocaine and mexiletine are class 1B antiarrhythmic drugs that act on sodium channels. Lidocaine is also an important anesthetic and topical agent that is useful in the treatment of multiple pain disorders, and mexiletine is commonly used for neuropathic pain and myotonia. Both intravenous lidocaine and mexiletine are increasingly used to treat pain syndromes and appear to be particularly effective in neuropathic pain. This suggests a role for these agents in patients with headache disorders. This article describes the role of intravenous lidocaine and mexiletine in the management of headache and trigeminal autonomic cephalalgias based on the published literature to date and provides practical guidelines for their use.
KeywordsCluster SUNCT Lidocaine Chronic daily headache
Dr. Michael J. Marmura has received funding from Merck for clinical research and has received compensation from Cephalon for speaking fees.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004, 24(Suppl 1):44–54.Google Scholar
- 9.Wyse DG, Morganroth J, Ledingham R, et al.: New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators. J Am Coll Cardiol 1994, 23:1130–1140.PubMedGoogle Scholar
- 14.Fuster V, Rydén LE, Asinger RW, et al.: ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001, 38:1231–1266.CrossRefPubMedGoogle Scholar
- 31.Herroeder S, Pecher S, Schönherr ME, et al.: Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial. Ann Surg 2007, 246:192–200. (Published erratum appears in Ann Surg 2009, 249:701.)Google Scholar
- 46.Burke M: Intravenous lignocaine for migraine headache. Aust Fam Physician 1989,18:1559. (Published erratum appears in Aust Fam Physician 1990, 19:598.)Google Scholar
- 52.• Rosen N, Marmura M, Abbas M, Silberstein S: Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. Headache 2009, 49:286–291. (Published erratum appears in Headache 2009, 49:803.). This is a large review of IV lidocaine in the treatment of chronic daily headache, including CH.CrossRefPubMedGoogle Scholar
- 65.Arroyo AM, Durán XR, Beldarrain MG, et al.: Response to intravenous lidocaine in a patient with SUNCT syndrome. Cephalalgia 2009 Apr 30 (Epub ahead of print).Google Scholar